We are live on ! Find out more
BCM

Buckhead Capital Management Portfolio holdings

AUM $292M
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
-4.5%
1 Year Est. Return
+21.14%
3 Year Est. Return
+67.58%
5 Year Est. Return
+91.22%
10 Year Est. Return
+290.19%
AUM
$386M
AUM Growth
-$17.7M
Cap. Flow
+$2.47M
Cap. Flow %
0.64%
Top 10 Hldgs %
29.15%
Holding
129
New
3
Increased
41
Reduced
53
Closed
6

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$7.41M
2
JJSF icon
J&J Snack Foods
JJSF
+$2.34M
3
META icon
Meta Platforms (Facebook)
META
+$1.17M
4
CF icon
CF Industries
CF
+$1.15M
5
AAPL icon
Apple
AAPL
+$941K

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Healthcare 15.97%
3 Financials 13.74%
4 Consumer Staples 11.46%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRW icon
126
C.H. Robinson
CHRW
$17.5B
-2,010
Closed -$204K
FDX icon
127
FedEx
FDX
$75.4B
-966
Closed -$219K
LOW icon
128
Lowe's Companies
LOW
$125B
-1,350
Closed -$236K
NVS icon
129
Novartis
NVS
$297B
-87,629
Closed -$7.41M

Similar funds

Buckhead Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Buckhead Capital Management held 129 positions worth $386M, down 4.4% from $404M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Buckhead Capital Management's Q3 2022 filing shows 3 new, 41 increased, 53 reduced and 6 closed positions. Its largest new stake was GSK: 235,278 shares worth $6.92M. The largest sale was Novartis, an estimated $7.41M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Buckhead Capital Management's largest Q3 2022 buy was GSK: 235,278 shares worth $6.92M.
  • Buckhead Capital Management added most to Air Products & Chemicals in Q3 2022, an estimated $1.99M increase.
  • Buckhead Capital Management's biggest Q3 2022 reduction was J&J Snack Foods, cutting an estimated $2.34M.
  • Buckhead Capital Management fully exited Novartis in Q3 2022, selling an estimated $7.41M.
  • Buckhead Capital Management's ten largest holdings make up 29% of its $386M portfolio in Q3 2022.
  • Buckhead Capital Management opened 3 new positions and closed 6 in Q3 2022.
  • Buckhead Capital Management's portfolio value fell 4.4% quarter-over-quarter to $386M.

Based on Buckhead Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.